Trial Profile
Fluorescence-guided Resection of Malignant Gliomas With 5-Aminolevulinic Acid (5-ALA) vs. Conventional Resection
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 02 Mar 2021
Price :
$35
*
At a glance
- Drugs Aminolevulinic acid (Primary)
- Indications Glioma
- Focus Diagnostic use; Registrational
- Sponsors Medac
- 25 Feb 2021 Results published in the Medexus Pharmaceuticals Media Release
- 10 Sep 2020 Results presented in the Medexus Pharmaceuticals Media Release.
- 09 Apr 2014 New trial record